"Continuous Opportunities for Academic Exchange"

PharmaResearch announced on August 20 that it held an online academic seminar the previous day to present clinical findings on its biosimulator containing PLLA (Poly-L-lactic acid), 'Evercoll', and botulinum toxin, 'LienTox'.


The webinar-style seminar was attended by around 500 domestic healthcare professionals.

PharmaResearch Successfully Concludes Academic Seminar on Evercoll and LienTox View original image

Lee Jungwoo, Chief Director of Elev Clinic and presenter at the seminar, introduced the unique features of Evercoll and LienTox, and provided optimized treatment protocols for muscle and dermal layers. He explained, using real clinical cases, how both products can be practically utilized in clinical settings depending on the patient's skin condition and the pattern of aging in different areas.



A representative from PharmaResearch stated, “Going forward, we will continue to expand education programs on Evercoll and LienTox that healthcare professionals can apply in actual clinical settings. We will also provide ongoing opportunities for both online and offline academic exchanges, sharing the latest procedural trends and clinical insights.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing